Literature DB >> 9682143

NMR spectroscopy in pharmacy.

U Holzgrabe1, B W Diehl, I Wawer.   

Abstract

Since drugs in clinical use are mostly synthetic or natural products, NMR spectroscopy has been mainly used for the elucidation and confirmation of structures. For the last decade, NMR methods have been introduced to quantitative analysis in order to determine the impurity profile of a drug, to characteristic the composition of drug products, and to investigate metabolites of drugs in body fluids. For pharmaceutical technologists, solid state measurements can provide information about polymorphism of drug powders, conformation of drugs in tablets etc. Micro-imaging can be used to study the dissolution of tablets, and whole-body imaging is a powerful tool in clinical diagnostics. Taken together, this review covers applications of NMR spectroscopy in drugs analysis, in particular, methods of international pharmacopoeiae, pharmaceutics and pharmacokinetics. The authors have repeated many of the methods describe in their own laboratories.

Mesh:

Year:  1998        PMID: 9682143     DOI: 10.1016/s0731-7085(97)00276-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Medication contaminants as a potential cause of anaphylaxis to vincristine.

Authors:  David A Hill; Allison Barz Leahy; Joseph Sciasci; Sean P O'Neill; Anne Reilly; Naomi Balamuth; Steven H Seeholzer; Jonathan M Spergel; Terri F Brown-Whitehorn
Journal:  Pediatr Blood Cancer       Date:  2017-08-22       Impact factor: 3.167

2.  Pharmaceutical analysis by NMR can accommodate strict impurity thresholds: The case of choline.

Authors:  Prabhakar S Achanta; Matthias Niemitz; J Brent Friesen; Fatkhulla K Tadjimukhamedov; Anton Bzhelyansky; Gabriel I Giancaspro; Shao-Nong Chen; Guido F Pauli
Journal:  J Pharm Biomed Anal       Date:  2022-03-05       Impact factor: 3.935

Review 3.  Analysis and characterization of heparin impurities.

Authors:  Szabolcs Beni; John F K Limtiaco; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-03       Impact factor: 4.142

4.  NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements.

Authors:  Dirk W Lachenmeier; Yulia B Monakhova; Thomas Kuballa; Sigrid Löbell-Behrends; Sibylle Maixner; Matthias Kohl-Himmelseher; Asja Waldner; Christian Steffen
Journal:  Chin Med       Date:  2012-03-22       Impact factor: 5.455

5.  Method development in quantitative NMR towards metrologically traceable organic certified reference materials used as (31)P qNMR standards.

Authors:  Michael Weber; Christine Hellriegel; Alexander Rueck; Juerg Wuethrich; Peter Jenks; Markus Obkircher
Journal:  Anal Bioanal Chem       Date:  2014-11-22       Impact factor: 4.142

6.  A statistical-textural-features based approach for classification of solid drugs using surface microscopic images.

Authors:  Fahima Tahir; Muhammad Abuzar Fahiem
Journal:  Comput Math Methods Med       Date:  2014-10-13       Impact factor: 2.238

7.  Structural studies of two capsaicinoids: dihydrocapsaicin and nonivamide. 13C and 15N MAS NMR supported by genetic algorithm and GIAO DFT calculations.

Authors:  Paweł Siudem; Jarosław Bukowicki; Iwona Wawer; Katarzyna Paradowska
Journal:  RSC Adv       Date:  2020-05-11       Impact factor: 3.361

8.  Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Authors:  Nadiya Druzhyna; Bartosz Szczesny; Gabor Olah; Katalin Módis; Antonia Asimakopoulou; Athanasia Pavlidou; Petra Szoleczky; Domokos Gerö; Kazunori Yanagi; Gabor Törö; Isabel López-García; Vassilios Myrianthopoulos; Emmanuel Mikros; John R Zatarain; Celia Chao; Andreas Papapetropoulos; Mark R Hellmich; Csaba Szabo
Journal:  Pharmacol Res       Date:  2016-08-10       Impact factor: 7.658

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.